The GMRF Clinical Trials Unit is currently recruiting for the following clinical trials in liver/gastric cancer:

PROTOCOL: MK3475-966 (PI: DR WARREN JOUBERT)

Protocol Title: A Phase 3 Randomized, Double Blind Study of Pembrolizumab Plus Gemcitabine/Cisplatin versus Placebo Plus Gemcitabine/Cisplatin as First-Line Therapy in Participants with Advanced and/or Unresectable Biliary Tract Carcinoma

Click here for more information

PROTOCOL: MK7902-017 (PI: DR WARREN JOUBERT)

Protocol Title: A Phase 3 Randomized Study of Lenvatinib in Combination With Pembrolizumab Versus Standard of Care in Participants With Metastatic Colorectal Cancer Who Have Received and Progressed On or After or Became Intolerant to Prior Treatment

Lay Title: Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer

Click here for more information